LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss
We believe Foundayo can help level the playing field for those living with obesity or who are overweight and living with weight-related complications, said David Ricks, chair and chief executive officer of Eli Lilly, in a statement
Despite its widespread prevalence, NAFLD is frequently underdiagnosed and undertreated, making early intervention essential for preventing long-term complications
By reducing melanin synthesis, glutathione helps to achieve remarkable results: Even Out Skin Tone: Regular use of glutathione can lead to a more uniform complexion, minimizing the appearance of redness and blotchiness
By Chrissie Ott, MD Summer 2026 As a physician, coach and mother, Ive learned that conversations about Read Article By Ankit Kushwaha, MD, FACP Summer 2026 Asthma and obesity are two of the most common Read Article By Sarah Bramblette, MSHL, OAC Senior Advocacy Manager Summer 2026 Several years ago, I was offered Read Article